Vaginal colonisation with Candida species with special focus on Candida dubliniensis. A prospective study;Die vaginale kolonisation durch Candidaarten unter besonderer berücksichtigung von Candida dubliniensis

Geburtshilfe und Frauenheilkunde

Volumn 67, Issue 10, 2007, Pages 1132-1137

  Mendling, Werner ^a,c   Niemann, D ^a   Tintelnot, K ^b  

^a Vivantes Klinika Am Urban und im Friedrichshain   (Germany)

^b ROBERT KOCH INSTITUTE   (Germany)

^c VIVANTES KLINIKUM IM FRIEDRICHSHAIN   (Germany)

Author keywords

Candida dubliniensis; Candida species; HIV; Susceptibility to fluconazole; Vagina

Indexed keywords

FLUCONAZOLE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANDIDA DUBLINIENSIS; CONTROLLED STUDY; FEMALE; FUNGAL COLONIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; POSTMENOPAUSE; PREMENOPAUSE; VAGINA CANDIDIASIS;

EID: 36049017112     PISSN: 00165751     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-965681     Document Type: Article

References (37)

1. Mendling W. Vaginose, Vaginitis und Zervizitis. Heidelberg: Springer, 1995
2. Nguyen MH, Peacock JE Jr, Morris AJ et al. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am J Med 1996; 100: 617-623
3. Voss A, le Noble JL, Verduyn Lunel FM, Foudraine NA, Meis JF. Candidemia in intensive care unit patients: risk factors for mortality. Infection 1997; 25: 8-11
4. Sobel JD, Zervos M, Reed BD, Hooton T, Soper D, Nyirjesy P, Heine MW, Willems J, Panzer H. Fluconazole susceptibility of vaginal isolates obtained from women with complicated Candida vaginitis: clinical implications. Antimicrob Agents Chemother 2003; 47: 34-38
5. Sullivan DJ, Westerneng TJ, Haynes KA, Bennet DE, Coleman DC. Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiol 1995; 141: 1507-1521
6. Saporiti AM, Gomez D, Levalle S et al. Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use. Rev Argent Microbiol 2001; 33: 217-222
7. Bauters TG, Dhont MA, Temmerman MI, Nelis HJ. Prevalence of vulvovaginal candidiasis and susceptibility to fluconazole in women. Am J Obstet Gynecol 2002; 187: 569-574
8. Sobel JD. Vulvovaginitis due to Candida glabrata. An emerging problem. Mycoses 1998; 41: 18-21
9. Odds FC, Bernaerts R. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J Clin Microbiol 1994; 32: 1923-1929
10. Tintelnot K, Haase G, Seibold M et al. Evaluation of phenotypic markers for selection and identification of Candida dubliniensis. J Clin Microbiol 2000; 38: 1599-1608
11. Graf B, Trost A, Eucker J, Göbel UB, Adam T. Rapid and simple differentiation of C. dubliniensis from C. albicans. Diagn Microbiol Infect Dis 2003; 48: 149-151
12. Lodder J. The Yeasts, A Taxonomic Study. North Holland: Publishing Company, 1971
13. Jansons VK, Nickerson WJ. Induction, morphogenesis and germination of the chlamydospores of Candida albicans. J Bacteriol 1970; 104: 910-921
14. Staib F. Cryptococcus neoformans und Guizotia abyssinica (syn. G. oleifera D.C.). Farbreaktion für Cr. neoformans. Z Hyg 1962; 148: 466-475
15. Staib P, Morschhäuser J. Chlamydospore formation on Staib agar as a species-specific characteristic of Candida dubliniensis. Mycoses 1999; 42: 521-524
16. Seibold M, Antweiler E, Raddatz B, Tintelnot K. Nachweis von C. dubliniensis in Primärkulturen auf Nigersaat-Agar. Mycoses 2001; 44: 228
17. Mosaid AA, Sullivan D, Salkin IF, Shanley D, Coleman DC. Differentiation of C. dubliniensis from Candida albicans on Staib agar and caffeic acid-ferric citrate agar. J Clin Microbiol 2001; 39: 323-327
18. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts M27-A. National Committee for Clinical Laboratory Standards, Wayne Pa., 1997
19. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts. 2nd ed. Approved standard M27-A2. National Committee for Clinical Laboratory Standards, Wayne, Pa., 2002
20. Mendling W, Seebacher C. Guideline vulvovaginal candidosis: Guideline of the German Dermatological Society, the German Speaking Mycological Society and the Working Group for Infections and Infectimmunology of the German Society for Gynecology and Obstetrics. Mycoses 2003; 46: 365-369
21. Fidel PL, Cutright J, Steele C. Effects of reproductive hormones on experimental vaginal Candidiasis. Infection and Immunity 2000; 68: 651-657
22. Sobel JD. Fungal Infections of the Genitourinary Tract. In: Anaissee EJ, McGinnis MR, Pfaller MA (eds). Clinical Mycology. New York: Churchill Livingstone, 2003: 496-508
23. Tarry W, Fisher M, Shen S, Mawshinney M. Candida albicans: The estrogen target for vaginal colonization. J Surg Res 2005; 129: 278-282
24. Kaur R, Domergue R, Zupancic ML, Cormack BP. A yeast by any other name: Candida glabrata and its interaction with the host. Curr Opin Microbiol 2005; 8: 378-384
25. Redondo-Lopez V, Lynch M, Schmitt C, Cook R, Sobel JD. Torulopsis glabrata vaginitis: clinical aspects and susceptibility to antifungal agents. Obstet Gynecol 1990; 76: 651-655
26. Sobel JD. Limitations of antifungal agents in the treatment of Candida vaginitis: future challenges. Drug Resistance Updates 1990; 2: 148-152
27. Vazquez JA, Sobel JD, Peng G. Evolutions of vaginal Candida species recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis: the emergence of Candida glabrata? Terry Beirn Community Programs for Clinical Research in AIDS (CPCRA). Clin Infect Dis 1999; 28: 1025-1031
28. Schnell JD. Vaginalmykose und perinatale Pilzinfektion. Basel: Karger, 1982
29. Schnell JD. "Soorprophylaxe" in der Schwangerschaft. Frauenarzt 1986; 5: 19-26
30. Mendling W, Schnell JD. Antepartale vaginale Hefekontamination heute. Mykosen 1984; 27: 573-578
31. Schnell JD, Andrews P, Plempel M. Die vaginale Kontamination der weiblichen Bevölkerung einer Großstadt mit Trichomonaden und Hefen. Geburtsh Frauenkheilk 1972; 32: 1007-1014
32. Mendling W, Krauss C, Fladung B. A clinical multicenter study comparing efficacy and tolerability of topical combination therapy with clotrimazole (Canesten®, two formats) with oral single dose fluconazole (Diflucan®) in vulvovaginal mycoses. Mycoses 2004; 47: 136-142
33. Walker PP, Reynolds MT, Ashbee HR, Brown C, Evans EG. Vaginal yeasts in the era of "over the counter" antifungals. Sex Transm Infect 2000; 76: 437-438
34. Yang CW, Barkham TMS, Chan FY, Wang Y. Prevalence of Candida species, including Candida dubliniensis, in Singapore. J Clin Microbiol 2003; 41: 472-474
35. Al-Sweih N, Ahmad S, Khan ZU, Khan S, Chandy R. Prevalence of Candida dubliniensis amoung germ tube positive candida isolates in a maternity hospital in Kuwait. Mycoses 2005; 48: 347-351
36. Beigi RH, Meyn LA, Moore DM, Krohn MA, Hillier SL. Vaginal yeast colonization in nonpregnant women: a longitudinal study. Obstet Gynecol 2004; 104: 926-930
37. Ohmit SE, Sobel JD, Schumann P, Duerr A, Mayer K, Rompalo A, Klein RS. Longitudinal study of mucosal candida species colonization und candidiasis among human immunodeficiency virus (HIV) - seropositive and at-risk HIV-seronegative women. J Infect Dis 2003; 188: 118-127